| Michael Warren Kuchera, MD | |
|
160 E Hanover Ave, Suite 101, Cedar Knolls, NJ 07927-2000 | |
| (973) 605-5090 | |
| (973) 605-1705 |
| Full Name | Michael Warren Kuchera |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 160 E Hanover Ave, Cedar Knolls, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215041348 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 25MA05645700 (New Jersey) | Primary |
| Entity Name | Summit Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942254347 PECOS PAC ID: 5395642276 Enrollment ID: O20031218000011 |
News Archive
Today's hospitals are challenged to become better prepared to manage large numbers of patients from mass casualty incidents (MCI), hazardous material incidents (HAZMAT), or in extreme cases, attacks using weapons of mass destruction (WMD).
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
Optimer Pharmaceuticals, Inc. has announced that the United States Patent and Trademark Office issued a production patent (U.S. Patent No. 7,507,564) covering steps used in the manufacture of fidaxomicin, which is currently in its second Phase 3 clinical trial for the treatment of Clostridium difficile infection, or CDI.
President Barack Obama is requesting an increase of $215 million in the 2016 federal budget to launch the Precision Medicine Initiative. This boost in funding for research will give genetic causes of cancer a national focus specifically around precision or "personalized" treatments for cancer in the future.
A microbe found in the colon and commonly associated with the development of colitis and colon cancer also may play a role in the development of some breast cancers, according to new research from investigators with the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Warren Kuchera, MD Po Box 1368, Morristown, NJ 07962-1368 Ph: (973) 605-5090 | Michael Warren Kuchera, MD 160 E Hanover Ave, Suite 101, Cedar Knolls, NJ 07927-2000 Ph: (973) 605-5090 |
News Archive
Today's hospitals are challenged to become better prepared to manage large numbers of patients from mass casualty incidents (MCI), hazardous material incidents (HAZMAT), or in extreme cases, attacks using weapons of mass destruction (WMD).
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
Optimer Pharmaceuticals, Inc. has announced that the United States Patent and Trademark Office issued a production patent (U.S. Patent No. 7,507,564) covering steps used in the manufacture of fidaxomicin, which is currently in its second Phase 3 clinical trial for the treatment of Clostridium difficile infection, or CDI.
President Barack Obama is requesting an increase of $215 million in the 2016 federal budget to launch the Precision Medicine Initiative. This boost in funding for research will give genetic causes of cancer a national focus specifically around precision or "personalized" treatments for cancer in the future.
A microbe found in the colon and commonly associated with the development of colitis and colon cancer also may play a role in the development of some breast cancers, according to new research from investigators with the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.
› Verified 1 days ago
Sarah Kelley Potash, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 E Hanover Ave, Suite 101, Cedar Knolls, NJ 07927 Phone: 973-605-5090 Fax: 973-605-1705 | |
James Joseph Kuchera, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 160 E Hanover Ave, Suite 101, Cedar Knolls, NJ 07927 Phone: 973-605-5090 Fax: 973-605-1705 | |
Mary Chu, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 160 E Hanover Ave, Cedar Knolls, NJ 07927 Phone: 973-605-5090 Fax: 973-605-1705 | |
Dr. Roshni Dinesh Patel, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 E Hanover Ave, Cedar Knolls, NJ 07927 Phone: 973-605-5090 |